natgillin/translations-raw huggingface dataset:
231 PARTICULARS TO APPEAR ON THE OUTER PACKAGING
231 PODATKI NA ZUNANJI OVOJNINI
OUTER CARTON 120 micrograms PRE-FILLED SYRINGE
ZUNANJA OVOJNINA – 120 mikrogramov NAPOLNJENA INJEKCIJSKA BRIZGA
MIRCERA 120 micrograms/0.3 ml solution for injection in pre-filled syringe methoxy polyethylene glycol-epoetin beta
MIRCERA 120 mikrogramov/ 0, 3 ml raztopina za injiciranje v napolnjeni injekcijski brizgi metoksipolietilenglikol epoetin beta
1 pre-filled syringe contains 120 micrograms of methoxy polyethylene glycol-epoetin beta.
1 napolnjena injekcijska brizga vsebuje 120 mikrogramov metoksipolietilenglikol epoetina beta.
232 10.
232 10.
233 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
233 PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH
MIRCERA 120 µg/0.3 ml injection methoxy polyethylene glycol-epoetin beta SC/IV
MIRCERA 120 μg/ 0, 3 ml injekcija metoksipolietilenglikol epoetin beta s. c. / i. v.
234 PARTICULARS TO APPEAR ON THE OUTER PACKAGING
234 PODATKI NA ZUNANJI OVOJNINI
OUTER CARTON 360 micrograms PRE-FILLED SYRINGE
ZUNANJA OVOJNINA – 360 mikrogramov NAPOLNJENA INJEKCIJSKA BRIZGA
MIRCERA 360 micrograms/0.6 ml solution for injection in pre-filled syringe methoxy polyethylene glycol-epoetin beta
MIRCERA 360 mikrogramov/ 0, 6 ml raztopina za injiciranje v napolnjeni injekcijski brizgi metoksipolietilenglikol epoetin beta
1 pre-filled syringe contains 360 micrograms of methoxy polyethylene glycol-epoetin beta.
1 napolnjena injekcijska brizga vsebuje 360 mikrogramov metoksipolietilenglikol epoetina beta.
235 10.
235 10.
236 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
236 PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH
MIRCERA 360 µg/0.6 ml injection methoxy polyethylene glycol-epoetin beta SC/IV
MIRCERA 360 μg/ 0, 6 ml injekcija metoksipolietilenglikol epoetin beta s. c. / i. v.
237 B.
237 B.
238 PACKAGE LEAFLET:
238 NAVODILO ZA UPORABO
MIRCERA 50 micrograms/ml solution for injection 100 micrograms/ml solution for injection 200 micrograms/ml solution for injection 300 micrograms/ml solution for injection 400 micrograms/ml solution for injection 600 micrograms/ml solution for injection 1000 micrograms/ml solution for injection
MIRCERA 50 mikrogramov/ ml raztopina za injiciranje 100 mikrogramov/ ml raztopina za injiciranje 200 mikrogramov/ ml raztopina za injiciranje 300 mikrogramov/ ml raztopina za injiciranje 400 mikrogramov/ ml raztopina za injiciranje 600 mikrogramov/ ml raztopina za injiciranje 1000 mikrogramov/ ml raztopina za injiciranje
What MIRCERA is and what it is used for 2.
Kaj je zdravilo MIRCERA in za kaj ga uporabljamo 2.
Before you use MIRCERA 3.
Kaj morate vedeti, preden boste uporabili zdravilo MIRCERA 3.
How to use MIRCERA 4.
Kako uporabljati zdravilo MIRCERA 4.
How to store MIRCERA 6.
Shranjevanje zdravila MIRCERA 6.
WHAT MIRCERA IS AND WHAT IT IS USED FOR
KAJ JE ZDRAVILO MIRCERA IN ZA KAJ GA UPORABLJAMO
This medicine is prescribed to you because you have anaemia caused by your chronic kidney disease and associated with typical symptoms such as tiredness, weakness and shortness of breath.
Zdravilo so vam predpisali, ker imate anemijo, ki jo je povzročila kronična bolezen vaših ledvic in je povezana s tipičnimi simptomi, kot so utrujenost, oslabelost in pojemanje sape.
This means that you have too few red blood cells and your haemoglobin level is too low (your body’s tissues might not receive enough oxygen)..
To pomeni, da imate premajhno število rdečih krvnih celic ter premajhno koncentracijo hemoglobina (vaša telesna tkiva lahko zato dobijo premalo kisika).
MIRCERA is used to treat only the symptomatic anaemia caused by your chronic kidney disease.
Zdravilo MIRCERA uporabljamo le za zdravljenje simptomatske anemije, ki jo povzroča kronična ledvična bolezen.
It has not been shown that MIRCERA can be used to treat anaemia caused by other diseases.
Ni bilo dokazano, da lahko zdravilo MIRCERA uporabljamo za zdravljenje anemije, povzročene z drugimi boleznimi.
Compared to other medicines of the same class called erythropoiesis stimulating agents (or ESA), MIRCERA can stay in your body longer, therefore fewer injections are required for your treatment.
V primerjavi z drugimi zdravili istega terapevtskega razreda, ki jih imenujemo zdravila za spodbujanje eritropoeze, lahko MIRCERA ostane v vašem telesu dlje, zato je za zdravljenje z njo potrebnih manj injekcij.
BEFORE YOU USE MIRCERA
KAJ MORATE VEDETI, PREDEN BOSTE UPORABILI ZDRAVILO MIRCERA
Do not use MIRCERA
Ne uporabljajte zdravila MIRCERA
- if you are allergic (hypersensitive) to methoxy polyethylene glycol-epoetin beta or to any of the
- če ste alergični na (preobčutljivi za) metoksipolietilenglikol epoetin beta ali katerokoli sestavino
other ingredients of MIRCERA (see section 6)
zdravila MIRCERA (glejte poglavje 6); če imate visok krvni tlak, ki ni obvladljiv.
- if you have high blood pressure that cannot be controlled
-
239 Take special care with MIRCERA
239 Bodite posebno pozorni pri uporabi zdravila MIRCERA
MIRCERA is indicated to treat only the symptomatic anaemia caused by chronic kidney disease.
Zdravilo MIRCERA je indicirano le za zdravljenje simptomatske anemije, ki jo povzroča kronična ledvična bolezen.
Before treatment with MIRCERA
- Pri nekaterih bolnikih, zdravljenih z drugimi zdravili za spodbujanje eritropoeze, so opazili
- A condition called Pure Red Cell Aplasia (stopped or reduced production of red blood cells) due
stanje imenovano čista aplazija rdečih krvnih celic (prekinjeno ali zmanjšano nastajanje rdečih krvnih celic), ki nastane zaradi protiteles proti eritropoetinu.
to anti-erythropoietin antibodies was observed in some patients treated with other ESAs. – If your doctor suspects or confirms that you have these antibodies in your blood you must not be treated with MIRCERA.
- Če vaš zdravnik sumi ali potrdi, da imate ta protitelesa v svoji krvi, se ne smete zdraviti z
- If you are a cancer patient be aware that MIRCERA, like other ESAs may act as a growth
- Če imate raka, bodite pozorni na podatek, da zdravilo MIRCERA, kot druga zdravila za
factor.
spodbujanje eritropoeze, lahko deluje kot rastni dejavnik.
- It is not known if MIRCERA has a different effect in patients with haemoglobinopathies
- Ni znano, ali ima zdravilo MIRCERA drugačen učinek pri bolnikih s hemoglobinopatijami
(disorders associated with abnormal haemoglobin), past or present bleeding, seizures or with a high blood platelet count.
(motnja povezana z nenormalnim hemoglobinom), krvavitvijo v preteklosti ali sedanjosti, epileptičnimi napadi ali velikim številom trombocitov v krvi.
If you have any of these conditions your doctor will discuss it with you and must treat you with caution.
Če imate katerokoli od navedenih stanj, se bo vaš zdravnik o tem pogovoril z vami in vas skrbno zdravil.
Using it can lead to too high haemoglobin levels and
- Zdravi ljudje ne smejo prejemati zdravila MIRCERA, ker bi lahko pretirano povečalo njihovo
cause problems with the heart or blood vessels that may be life-threatening.
koncentracijo hemoglobina in povzročilo težave s srcem ali krvnimi žilami, ki so lahko življenjsko nevarne.
- Your doctor may initiate treatment with MIRCERA if your haemoglobin level is 10 g/dl (6.21
- Vaš zdravnik lahko uvede zdravljenje z zdravilom MIRCERA, če je vaša koncentracija
mmol/l) or less.
hemoglobina 10 g/ dl (6, 21 mmol/ l) ali manj.
After initiation of therapy, your doctor will seek to maintain your haemoglobin level between 10 and 12 g/dl (7.45 mmol/l). – Your doctor will check the amount of iron in your blood before and during MIRCERA treatment.
- Zdravnik bo pred in med zdravljenjem z zdravilom MIRCERA preverjal količino železa v vaši
- Your doctor will check your blood pressure before and during your MIRCERA treatment.
- Zdravnik vam bo preverjal krvni tlak pred in med zdravljenjem z zdravilom MIRCERA.
If
Če bo
your blood pressure is high and cannot be controlled either by appropriate medicines or a special diet, your doctor will interrupt your MIRCERA treatment or reduce the dose.
krvni tlak visok in ga ne bo mogoče uravnati z ustreznimi zdravili ali dieto, bo zdravnik zdravljenje z zdravilom MIRCERA prekinil ali pa bo zmanjšal njegov odmerek.
- Your doctor will check that your haemoglobin does not exceed a certain level, as high
- Zdravnik bo pazil, da koncentracija vašega hemoglobina ne bo narastla nad določeno vrednost,
haemoglobin could put you at risk of having a problem of the heart or the blood vessels and could increase risk of death.
saj bi bili zaradi velike koncentracije hemoglobina lahko ogroženi zaradi težav s srcem ali krvnimi žilami, povečalo pa bi se lahko tudi tveganje za smrt.
- Contact your doctor if you feel tired, weak or have shortness of breath as this could mean that
- Če se počutite utrujeni, oslabeli ali imate kratko sapo, obvestite svojega zdravnika, ker to lahko
your MIRCERA treatment is not effective.
pomeni, da zdravljenje z zdravilom MIRCERA ni učinkovito.
If you have developed Pure Red Cell Aplasia your MIRCERA treatment will be discontinued.
Če bodo pokazale, da se je pri vas razvila čista aplazija rdečih krvnic celic, bo zdravljenje z zdravilom MIRCERA ukinil.
Children and adolescents Treatment with MIRCERA is not recommended in children and adolescents as it has not been studied in these patients.
Otroci in mladostniki Zdravljenje z zdravilom MIRCERA ni priporočljivo za bolne otroke in mladostnike, saj pri njih ni bilo raziskano.
Using MIRCERA with food and drink Food and drink do not affect MIRCERA.
Uporaba zdravila MIRCERA skupaj s hrano in pijačo Hrana in pijača ne vplivata na zdravilo MIRCERA.
Pregnancy and breast-feeding Ask your doctor or pharmacist for advice before taking any medicine.
240 Nosečnost in dojenje Posvetujte se z zdravnikom ali farmacevtom, preden vzamete katerokoli zdravilo.
240 Driving and using machines MIRCERA does not affect your ability to drive and use machines.
Vpliv na sposobnost upravljanja vozil in strojev Zdravilo MIRCERA ne vpliva na vašo sposobnost upravljanja vozil in strojev.
Important information about some of the ingredients of MIRCERA This medicine contains less than 1 mmol sodium (23 mg) per ml, i.e. essentially ‘sodium-free’.
Pomembne informacije o nekaterih sestavinah zdravila MIRCERA To zdravilo vsebuje manj kot 1 mmol natrija (23 mg) na odmerek, kar v bistvu pomeni ‛ brez natrija ’.
HOW TO USE MIRCERA
KAKO UPORABLJATI ZDRAVILO MIRCERA
Always use MIRCERA exactly as your doctor has told you.
Pri uporabi zdravila MIRCERA natančno upoštevajte zdravnikova navodila.
Treatment with MIRCERA must be started under the supervision of a healthcare professional.
Zdravljenje z zdravilom MIRCERA je treba začeti pod nadzorom zdravstvenega strokovnjaka.
Further injections can be given by a healthcare professional or, after you have been trained, you can inject MIRCERA yourself (see instructions at the end of this leaflet.)
Naslednje injekcije vam lahko daje zdravstveni strokovnjak ali pa si zdravilo MIRCERA injicirate sami potem, ko so vas o tem ustrezno poučili (glejte napotke na koncu tega navodila za uporabo).
- If you are not currently treated with an ESA
- Če se trenutno ne zdravite z zdravili, ki spodbujajo eritropoezo
The recommended starting dose of MIRCERA is 0.6 micrograms for every kilogram of your body weight.
Priporočeni začetni odmerek zdravila MIRCERA je 0, 6 mikrograma na kilogram telesne mase.
The dose is to be administered once every 2 weeks as a single injection.
Odmerek dajemo enkrat na 2 tedna v eni injekciji.
- If you are currently being treated with another ESA
- Če se trenutno zdravite z drugim zdravilom, ki spodbuja eritropoezo
If you use more MIRCERA than you should Please contact your doctor or pharmacist if you used too large a dose of MIRCERA as it may be necessary to perform some blood tests and interrupt your treatment.
Če ste uporabili večji odmerek zdravila MIRCERA, kot bi smeli Prosimo, posvetujte se s svojim zdravnikom ali farmacevtom, če ste uporabili večji odmerek zdravila MIRCERA, kot bi smeli.
If you forget to use MIRCERA If you miss a dose of MIRCERA administer the missed dose as soon as you remember and talk to your doctor about when to use the next doses.
Če ste pozabili uporabiti zdravilo MIRCERA Če ste izpustili odmerek zdravila MIRCERA, si izpuščeni odmerek injicirajte takoj, ko se spomnite, in se pogovorite s svojim zdravnikom o tem, kdaj naj uporabite naslednje odmerke.
If you stop using MIRCERA Treatment with MIRCERA is normally long-term.
241 Če ste prenehali uporabljati zdravilo MIRCERA Zdravljenje z zdravilom MIRCERA je običajno dolgotrajno.
Like all medicines, MIRCERA can cause side effects, although not everybody gets them.
Kot vsa zdravila ima lahko tudi MIRCERA neželene učinke, ki pa se ne pojavijo pri vseh bolnikih.
The frequency of possible side effects listed below is defined using the following convention: very common (affects more than 1 user in 10); common (affects 1 to 10 users in 100); uncommon (affects 1 to 10 users in 1’000); rare (affects 1 to 10 users in 10’000); very rare (affects less than 1 user in 10’000); not known (frequency cannot be estimated from the available data).
Pogostnost možnih neželenih učinkov, navedenih spodaj, je določena z uporabo naslednje konvencije: zelo pogosti (pojavi se pri več kot 1 bolniku od 10), pogosti (pojavi se pri 1 do 10 bolnikih od 100), občasni (pojavi se pri 1 do 10 bolnikih od 1. 000), redki (pojavi se pri 1 do 10 bolnikih od 10. 000), neznana (ni mogoče oceniti iz razpoložljivih podatkov).
A common side effect is hypertension (high blood pressure).
Pogost neželeni učinek je hipertenzija (visok krvni tlak).
- vascular access thrombosis (blood clots in your dialysis access).
- tromboza žilnega pristopa (strdki krvi v vašem dializnem pristopu).
- hypertensive encephalopathy (very high blood pressure that can result in headache, especially
- hipertenzivna encefalopatija (zelo visok krvni tlak, ki lahko sproži glavobol, zlasti nenaden,
sudden, stabbing, migraine -like headache, confusion, speech disturbances, fits or convulsions).
zbadajoč glavobol podoben migreni, zmedenost, motnje govora, epileptični napad ali krče).
- maculo-papular rash (red skin reaction that can include pimples or spots)
- makulopapulozni izpuščaj (rdeča kožna reakcija, ki lahko vključuje mozolje ali pege);
- hot flush
- vročinski valovi;
- hypersensitivity (allergic reaction that can cause unusual wheezing or difficulty in breathing;
- preobčutljivost (alergična reakcija, ki lahko povzroči nenavadno piskanje ali težave z dihanjem;
swollen tongue, face or throat, or swelling around the injection site, or make you feel light- headed, faint or cause you to collapse).
otekel jezik, obraz ali grlo ali oteklino okoli mesta injiciranja; ali pa se lahko počutite omotično, omedlite ali pa se zgrudite).
During clinical studies patients had a slight decrease in their platelet blood counts.
Med kliničnimi preskušanji so pri bolnikih opazili rahel upad števila trombocitov.
Some patients had platelet counts below the normal range.
Nekateri bolniki so imeli število trombocitov pod mejo normale.
HOW TO STORE MIRCERA
SHRANJEVANJE ZDRAVILA MIRCERA
Do not use MIRCERA after the expiry date which is stated on the outer carton and vial label after ‘EXP’.
Zdravila MIRCERA ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na zunanji ovojnini in nalepki viale poleg oznake EXP.
Store in a refrigerator (2 °C – 8 °C).
Shranjujte v hladilniku (2 °C − 8 °C).
You may remove MIRCERA from the refrigerator and store it at a room temperature not above 25 °C for a period of one month.
Zdravilo MIRCERA lahko vzamete iz hladilnika in ga shranite pri sobni temperaturi do 25 °C za obdobje enega meseca.
During this period when you have stored MIRCERA at a room temperature not above 25 °C you may not put MIRCERA back in the refrigerator before use.
V tem času, ko ste zdravilo MIRCERA hranili pri sobni temperaturi do 25 °C, zdravila pred uporabo ne smete vrniti nazaj v hladilnik.
Medicines should not be disposed of via wastewater or household waste.
Zdravila ne smete odvreči v odpadno vodo ali med gospodinjske odpadke.
Ask your pharmacist how to dispose of medicines that are no longer required.
242 O načinu odstranjevanja zdravila, ki ga ne potrebujete več, se posvetujte s farmacevtom.
- The active substance is methoxy polyethylene glycol-epoetin beta.
- Zdravilna učinkovina je metoksipolietilenglikol epoetin beta.
1 ml (one vial) contains 50
Ena viala z 1°ml vsebuje 50, 100,
100, 200, 300, 400, 600, 1000 micrograms methoxy polyethylene glycol-epoetin beta.
200, 300, 400, 600 ali 1000 mikrogramov metoksipolietilenglikol epoetina beta.
- The other ingredients are sodium dihydrogen phosphate monohydrate, sodium sulphate,
- Pomožne snovi so natrijev dihidrogenfosfat monohidrat, natrijev sulfat, manitol (E 421),
mannitol (E421), methionine, poloxamer 188 and water for injections.
metionin, poloksamer 188 in voda za injekcije.
What MIRCERA looks like and contents of the pack MIRCERA is a solution for injection in vial.
Izgled zdravila MIRCERA in vsebina pakiranja Viala z raztopino za injiciranje zdravila MIRCERA.
MIRCERA comes in glass vials with grey laminated rubber stopper and flip-off cap made in aluminium and plastic.
Zdravilo MIRCERA je na voljo v steklenih vialah s sivim laminiranim zamaškom in zaporko tipa flip - off iz aluminija in plastike.
Each vial contains 1ml of solution.
Vsaka viala vsebuje 1 ml raztopine.
One pack contains 1 vial.
Eno pakiranje vsebuje 1 vialo.
1 D-79639 Grenzach-Wyhlen Germany
1 D- 79639 Grenzach Wyhlen Nemčija
Deutschland Roche Pharma AG Tel: +49 (0) 7624 140
243 Norge Deutschland Roche Norge AS Roche Pharma AG Tlf: +47 - 22 78 90 00 Tel: +49 (0) 7624 140
Eesti Österreich Roche Eesti OÜ Tel: + 372 - 6 177 380
Österreich Eesti Roche Austria GmbH Roche Eesti OÜ Tel: +43 (0) 1 27739 Tel: + 372 - 6 177 380
This leaflet was last approved in {MM/YYYY}.
Navodilo je bilo odobreno {MM/ LLLL}
HOW TO SELF INJECT MIRCERA
244 KAKO SI SAMOSTOJNO INJICIRATE ZDRAVILO MIRCERA
MIRCERA can be self-injected by yourself either under the skin or if you are on haemodialysis, through the haemodialysis line according to your doctor’s advice.
Zdravilo MIRCERA si lahko daste sami pod kožo, če pa ste na hemodializi, boste zdravilo prejeli preko hemodializne krvne linije po zdravnikovih navodilih.
The vial does not contain any preservative and is to be used for one single injection only.
Viala ne vsebuje konzervansov in je namenjena le za enkratno injiciranje.
More than one dose must not be administered per vial.
Iz ene viale ne smemo dati več kot enega odmerka.
Do not mix the solution with other injectable medicines.
Ne mešajte raztopine z drugimi zdravili za injiciranje.
Store the vial in the outer carton box.
Shranjujte vialo v zunanji ovojnini.
244 Safety tips ● Remove the vial of MIRCERA from the refrigerator and allow it to reach room temperature in its outer carton box.
Varnostni napotki • Vzemite vialo zdravila MIRCERA iz hladilnika in jo pustite v zunanji ovojnini, da se bo prilagodila sobni temperaturi.
This should take about 30 minutes after the package has been removed from the fridge. ● Make sure that the vial has not been removed from the fridge for more than a single period or for longer than 1 month. ● Do not use a vial that has been frozen and do not expose it to temperatures above 25 °C. ● Do not use a vial after the expiry date stated on the label. ● Only use the vial if the solution is clear, colourless (slightly yellow in colour is acceptable) and is free of visible particles. ● Do not shake the vial. ● When handling syringes, do not touch the needles. ● Keep the syringes in their wrappers until you are ready to prepare your dose.
To naj traja približno 30 minut. • Viala ne sme biti zunaj hladilnika več kot en mesec in je ne smete vzeti iz hladilnika več kot enkrat. • Ne uporabljajte viale, če je bila zmrznjena; tudi ne izpostavljajte vial temperaturi nad 25 °C. • Ne uporabljajte vial po preteku roka uporabnosti, ki je označen na ovojnini. • Vialo lahko uporabite le, če je raztopina bistra, brezbarvna (rahlo rumena barva je sprejemljiva) in brez vidnih delcev. • Viale ne stresajte. • Pri ravnanju z brizgo pazite, da se ne boste dotaknili igle. • Injekcijske brizge hranite v njihovi ovojnini, dokler niste pripravljeni za pripravo vašega odmerka.
Getting started Assemble all of the supplies you will need for an injection on a clean surface:
Priprava Pripravite si vse potrebno za injiciranje na čisto površino.
Included in the pack: ● One vial of MIRCERA Not included in the pack: ● A syringe ● One long needle to withdraw MIRCERA from the vial ● One short needle for injection ● Cleansing alcohol swabs ● Sterile gauze ● Container for the waste material
V ovojnini ni: • injekcijske brizge, • dolge igle za odvzem zdravila MIRCERA iz viale, • kratke igle za injekcijo, • dezinfekcijske krpice, • sterilne gaze, • vsebnika za odpadni material.
The following instructions explain how to use MIRCERA vials to inject yourself.
Naslednja navodila opisujejo, kako si lahko zdravilo MIRCERA iz viale dajete sami.
Wash your hands thoroughly before you start.
Preden boste začeli, si skrbno umijte roke.
Preparing the dose of MIRCERA ● Remove the protective cap from the vial (1). ● Clean the rubber top of the vial with a cleansing alcohol swab.
Priprava odmerka zdravila MIRCERA Z viale odstranite zaščitno zaporko (1). ● Na viali pokrovček iz gume očistite z dezinfekcijsko krpico. ●
Do not touch the tip of the syringe. ● Take the needle guard containing the long needle and place it firmly on to the tip of the syringe (2).
Brizgo z iglo obdržite v roki. ● Iglo potisnite skozi gumijasti zamašek na viali (3). ●
245 ● Hold the vial firmly in one hand and the syringe in the other and turn both upside down (4).
Vialo in brizgo trdno primite v eno roko in ju obrnite navzgor (4). ●
● Keeping the vial upside down, slowly pull back on the plunger to fill the syringe with the solution to the line that matches the dose your doctor prescribed. ● Keeping the vial upside down and the needle in the vial, check for air bubbles in the syringe.
Ko je viala obrnjena navzdol, bat počasi potegnite nazaj in v brizgo zajemite raztopino do črte, ● ki odgovarja odmerku, ki vam ga je predpisal zdravnik.
To remove air bubbles, gently tap the syringe with your fingers until the air bubbles rise to the top of the syringe.
Držite vialo obrnjeno navzdol in z iglo v viali preverite, če so v brizgi zračni mehurčki.
Then slowly push the plunger up to push the solution and the air bubbles out of the syringe. ● Keep the tip of the needle in the liquid and once again pull the plunger back to the line on the syringe that matches your dose. ● Remove the syringe from the long needle while keeping the needle in the vial.
Vrh igle naj bo potopljen v raztopino.
Avoid touching the tip of the syringe. ● Take the needle guard containing the short injection needle and place it firmly on to the tip of the syringe (5).
Snemite brizgo z dolge igle, igla pa naj ostane v viali.
Injecting the solution If your doctor has advised you to inject MIRCERA through the haemodialysis line or into a vein, please administer your dose as shown by your health care professional.
246 Injiciranje raztopine Če vam je zdravnik svetoval dajanje zdravila MIRCERA preko hemodializne krvne linije ali v veno, si odmerek injicirajte tako, kot vam je pokazal zdravstveni strokovnjak.
If you are advised to inject MIRCERA under your skin please administer your dose as described below.
Če vam je svetoval dajanje zdravila MIRCERA pod kožo, si odmerek injicirajte tako kot je opisano spodaj.
246 ● Select the injection site in the abdomen, thigh or arm (except your navel or waistline) (6).
Izberite mesto injiciranja na trebuhu, stegnu ali roki (razen področja popka in pasu) (6). ●
● Clean the skin, where the injection is to be made with a cleansing alcohol swab. ● Wait for the area to dry. ● Remove the needle guard. ● With one hand, pinch a fold of loose skin.
Z alkoholno dezinfekcijsko krpico očistite kožo na mestu, kjer si boste dali injekcijo. ● Počakajte, da se koža posuši. ● Odstranite igelno zaščito. ● Z eno roko stisnite kožo v gubo.